Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
MARKETS
Strong On High Relative Volume: OpGen (OPGN)
By TheStreet Wire
Jul 22, 2016 10:01 AM EDT
PRESS RELEASES
OpGen Subsidiary Curetis And Annar Enter Into Unyvero Distribution Partnership For Colombia
By GlobeNewswire
Jan 5, 2021 7:30 AM EST
PRESS RELEASES
OpGen, Inc. Announces $10 Million Private Placement Priced At The Market
By GlobeNewswire
Nov 24, 2020 8:00 AM EST
PRESS RELEASES
OpGen Group Company Ares Genetics Commercially Launches NGS-based Antibiotic Resistance Testing Service For Native Specimens And Receives Bulk Order From Public Health Agency
By GlobeNewswire
Nov 12, 2020 7:30 AM EST
PRESS RELEASES
OpGen Announces Award Of German Government Grant Funding To Its Subsidiary Curetis And Collaborators
By GlobeNewswire
Oct 28, 2020 7:30 AM EDT
PRESS RELEASES
OpGen Provides Business And Pipeline Update And Announces Preliminary Unaudited Revenue And Cash Position For The Third Quarter 2020
By GlobeNewswire
Oct 15, 2020 7:30 AM EDT
PRESS RELEASES
OpGen Issues Formal Response To FDA's Requests For Additional Information And Expects Near Term FDA Clearance Decision For Acuitas AMR Gene Panel
By GlobeNewswire
Oct 13, 2020 5:00 PM EDT
PRESS RELEASES
OpGen Group Company Ares Genetics Wins Austrian Digitization Award For Ares-genetics.cloud
By GlobeNewswire
Oct 5, 2020 8:18 AM EDT
PRESS RELEASES
OpGen Announces Award Of German Government Grant Funding To Its Subsidiary Curetis And Collaborators
By GlobeNewswire
Sep 30, 2020 7:30 AM EDT
PRESS RELEASES
OpGen Announces Successful Completion Of Study Collaboration With Karolinska Institutet On Bacterial Co-Infections In COVID-19 Pneumonia Patients And Presents Data On Unyvero HPN Panel At ECCVID 2020
By GlobeNewswire
Sep 28, 2020 7:30 AM EDT
PRESS RELEASES
OpGen, Inc. Announces Notice Of Annual Meeting Venue Change
By GlobeNewswire
Sep 18, 2020 4:30 PM EDT
PRESS RELEASES
OpGen Group Company Ares Genetics Nominated For Austrian Innovation Award For AI-powered Molecular Antibiotic Susceptibility Test
By GlobeNewswire
Sep 8, 2020 7:30 AM EDT
PRESS RELEASES
Key Publication Of Clinical Study Demonstrates Unyvero Lower Respiratory Tract (LRT) Panel Is Likely To Alter Antibiotic Management Of Significant Numbers Of Patients Presenting With Suspected Pneumonia
By GlobeNewswire
Sep 2, 2020 7:30 AM EDT
PRESS RELEASES
OpGen Announces CE-IVD Marking And Commercial Launch In Europe Of Its Own Developed Molecular Diagnostic SARS-CoV-2 Kit With PULB For Detection Of The Virus Causing COVID-19
By GlobeNewswire
Aug 20, 2020 7:30 AM EDT
PRESS RELEASES
OpGen Co-Markets COVID-19 Antibody Test Kit
By GlobeNewswire
Aug 9, 2020 4:15 PM EDT
PRESS RELEASES
OpGen Provides Business Update And Announces Preliminary Unaudited Revenue And Cash Position For Second Quarter 2020
By GlobeNewswire
Jul 15, 2020 7:30 AM EDT
PRESS RELEASES
Menarini Silicon Biosystems Partners With OpGen To Broaden Distribution Of CELLSEARCH Platform In North America
By GlobeNewswire
Jul 13, 2020 7:30 AM EDT
PRESS RELEASES
OpGen Subsidiary Curetis GmbH Secures Access To Additional EUR 5.0 Million Non-Dilutive Debt Financing Tranche From EIB
By GlobeNewswire
Jul 9, 2020 11:59 AM EDT
PRESS RELEASES
OpGen Releases Preliminary Data Demonstrating Its Unyvero HPN Panel For Pneumonia Identifies Life-Threatening Bacterial Co-Infections In COVID-19 Patients In Just Five Hours
By GlobeNewswire
Jun 9, 2020 7:30 AM EDT
PRESS RELEASES
OpGen Expands Partnership With New York State Department Of Health And IDC To Detect Antimicrobial-Resistant Infections
By GlobeNewswire
Jun 3, 2020 6:00 AM EDT
PRESS RELEASES
OpGen Subsidiary Curetis GmbH And Karolinska Institutet Collaborate In Study Of Bacterial Co-Infections In COVID-19 Pneumonia Patients
By GlobeNewswire
Apr 21, 2020 9:00 AM EDT
PRESS RELEASES
OpGen Subsidiary Ares Genetics Demonstrates Feasibility And Potential Of Next Generation Sequencing Based Antibiotic Susceptibility Testing In Multi-Center Study
By GlobeNewswire
Apr 16, 2020 7:30 AM EDT
PRESS RELEASES
OpGen Announces Preliminary Unaudited Revenue And Cash Position For First Quarter 2020 And Provides Business Update
By GlobeNewswire
Apr 14, 2020 7:30 AM EDT
PRESS RELEASES
OpGen And Curetis Successfully Close Their Business Combination Transaction
By GlobeNewswire
Apr 1, 2020 4:00 PM EDT
PRESS RELEASES
OpGen Announces Shareholder Approval For Business Combination With Curetis
By GlobeNewswire
Mar 30, 2020 10:50 AM EDT